Company news: AstraZeneca; Everyday Health

Share this article:
An AstraZeneca survey of how the company's scientists use social media found that 71% participate in social media, and of those, 71% do so for science-related activities and 69% for personal reasons. Professional networks were the favorite social media channel of the 372 British, Swedish and American respondents to the survey, with 79% saying they participated in them, follwed by Wikis (53%), blogs (50%) and Yammer (48%). Just a quarter of those using social media said they participate in social networks. They're passive social surfers -- less than a fifth of them said they post comments, with 61% saying they read and watch content.

Everyday Health's monthly unique users tally ticked past 30 million in January according to comScore's Media Metrix. The portal trumpeted the stat, along with its inclusion in AlwaysOn's OnMedia Top 100 list of emerging companies in the media and marketing worlds.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.